From its earliest recognition as a polyuric wasting disease in antiquity, through its reclassification as a metabolic disorder in the insulin era, to its current status as a prototype of organ-specific autoimmunity, T1DM went through profound ontological shifts. This evidence concerns the gene INS and metabolic disease.